Atara Biotherapeutics Inc (ATRA)
0.5644
0.00 (0.00%)
USD |
NASDAQ |
May 31, 16:00
0.5854
+0.02
(+3.72%)
After-Hours: 20:00
Atara Biotherapeutics Enterprise Value: 21.72M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 21.72M |
| May 30, 2024 | 22.18M |
| May 29, 2024 | 21.19M |
| May 28, 2024 | 27.40M |
| May 24, 2024 | 28.90M |
| May 23, 2024 | 32.03M |
| May 22, 2024 | 38.03M |
| May 21, 2024 | 37.25M |
| May 20, 2024 | 39.26M |
| May 17, 2024 | 27.21M |
| May 16, 2024 | 26.44M |
| May 15, 2024 | 30.83M |
| May 14, 2024 | 26.61M |
| May 13, 2024 | 20.76M |
| May 10, 2024 | 17.57M |
| May 09, 2024 | 19.48M |
| May 08, 2024 | 21.86M |
| May 07, 2024 | 26.32M |
| May 06, 2024 | 29.60M |
| May 03, 2024 | 34.44M |
| May 02, 2024 | 32.07M |
| May 01, 2024 | 36.19M |
| April 30, 2024 | 36.85M |
| April 29, 2024 | 39.76M |
| April 26, 2024 | 36.85M |
| Date | Value |
|---|---|
| April 25, 2024 | 38.03M |
| April 24, 2024 | 39.82M |
| April 23, 2024 | 40.29M |
| April 22, 2024 | 37.74M |
| April 19, 2024 | 33.36M |
| April 18, 2024 | 37.05M |
| April 17, 2024 | 39.85M |
| April 16, 2024 | 35.84M |
| April 15, 2024 | 35.48M |
| April 12, 2024 | 38.95M |
| April 11, 2024 | 39.53M |
| April 10, 2024 | 40.12M |
| April 09, 2024 | 43.92M |
| April 08, 2024 | 44.73M |
| April 05, 2024 | 46.90M |
| April 04, 2024 | 47.48M |
| April 03, 2024 | 40.40M |
| April 02, 2024 | 41.32M |
| April 01, 2024 | 41.00M |
| March 31, 2024 | 37.27M |
| March 28, 2024 | 31.11M |
| March 27, 2024 | 31.83M |
| March 26, 2024 | 27.17M |
| March 25, 2024 | 28.23M |
| March 22, 2024 | 31.52M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-78.99M
Minimum
Nov 10 2023
1.716B
Maximum
Dec 07 2020
463.43M
Average
457.86M
Median
Dec 05 2019
Enterprise Value Benchmarks
| Biogen Inc | 38.21B |
| NovaBay Pharmaceuticals Inc | 4.387M |
| Palatin Technologies Inc | 19.03M |
| iBio Inc | 28.91M |
| Theriva Biologics Inc | -10.98M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -31.75M |
| Revenue (Quarterly) | 27.36M |
| Total Expenses (Quarterly) | 58.60M |
| EPS Diluted (Quarterly) | -0.23 |
| Gross Profit Margin (Quarterly) | 92.74% |
| Profit Margin (Quarterly) | -116.1% |
| Earnings Yield | -377.4% |
| Normalized Earnings Yield | -377.39 |